• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

门诊胃肠外抗菌治疗(OPAT):奥克兰医院经验综述

Outpatient Parenteral Antimicrobial Therapy (OPAT): a review of experience at Auckland Hospital.

作者信息

Upton Arlo, Ellis-Pegler Rod B, Woodhouse Andrew

机构信息

Department of Clinical Microbiology, Auckland City Hospital, Auckland, New Zealand.

出版信息

N Z Med J. 2004 Aug 20;117(1200):U1020.

PMID:15475990
Abstract

AIM

To review the Auckland Hospital Outpatient Parenteral Antimicrobial Therapy (OPAT) Service.

METHODS

Patients (>15 years of age) were referred to the Service and assessed for suitability for outpatient therapy by an infectious diseases physician and a specialist nurse. Patient demographics, referring service, site of infection, and infecting organism, antimicrobial agent/s and outcomes of treatment including complications were recorded.

RESULTS

Over a 20-month period 100 patients were treated with 107 courses of outpatient parenteral antibiotic therapy. Bone and joint infections accounted for close to two thirds (60%) of the referrals; discitis/osteomyelitis (36%), septic arthritis (14%) and infected metalware/prosthetic joint infections (10%). Staphylococcus aureus was the most frequently isolated organism (42%), and in 21% of cases no organism was identified. In general, antibiotics prescribed were narrow spectrum and all but six patients self-administered up to four times daily. Eighty-eight percent of treatment courses resulted in a cure. Complications related to therapy occurred in 35% of patients.

CONCLUSIONS

We have found that parenteral antibiotic therapy can be administered safely and successfully in an outpatient setting despite relatively frequent dosing intervals. The majority of complications were minor, and 88% of patients were cured.

摘要

目的

对奥克兰医院门诊胃肠外抗菌治疗(OPAT)服务进行评估。

方法

将年龄大于15岁的患者转至该服务部门,由传染病科医生和专科护士评估其是否适合门诊治疗。记录患者的人口统计学信息、转诊科室、感染部位、感染病原体、抗菌药物及治疗结果(包括并发症)。

结果

在20个月的时间里,100例患者接受了107个疗程的门诊胃肠外抗生素治疗。骨和关节感染占转诊病例的近三分之二(60%);椎间盘炎/骨髓炎(36%)、化脓性关节炎(14%)以及感染的金属植入物/人工关节感染(10%)。金黄色葡萄球菌是最常分离出的病原体(42%),21%的病例未鉴定出病原体。一般来说,所开的抗生素为窄谱抗生素,除6例患者外,所有患者每天自行给药多达4次。88%的治疗疗程取得了治愈效果。35%的患者出现了与治疗相关的并发症。

结论

我们发现,尽管给药间隔相对频繁,但胃肠外抗生素治疗在门诊环境中可以安全、成功地进行。大多数并发症较轻微,88%的患者得以治愈。

相似文献

1
Outpatient Parenteral Antimicrobial Therapy (OPAT): a review of experience at Auckland Hospital.门诊胃肠外抗菌治疗(OPAT):奥克兰医院经验综述
N Z Med J. 2004 Aug 20;117(1200):U1020.
2
[Outpatient parenteral antimicrobial therapy (OPAT) in bone and joint infections].[骨与关节感染的门诊胃肠外抗菌治疗(OPAT)]
Med Mal Infect. 2006 Mar;36(3):132-7. doi: 10.1016/j.medmal.2006.01.002. Epub 2006 Mar 31.
3
Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years.门诊胃肠外抗菌治疗(OPAT):对选定患者而言,在家自行给药是否安全?一项针对超过13年的大型队列的回顾性分析
J Antimicrob Chemother. 2007 Aug;60(2):356-62. doi: 10.1093/jac/dkm210. Epub 2007 Jun 11.
4
Outpatient parenteral antimicrobial therapy in osteoarticular infections in children.儿童骨关节炎感染的门诊胃肠外抗菌治疗
J Pediatr Orthop. 2002 Jul-Aug;22(4):506-10.
5
Outpatient parenteral antibiotic therapy for infective endocarditis: a review of 4 years' experience at a UK centre.英国某中心 4 年经验回顾:感染性心内膜炎的门诊患者肠外抗生素治疗。
Postgrad Med J. 2012 Jul;88(1041):377-81. doi: 10.1136/postgradmedj-2011-130355. Epub 2012 Feb 25.
6
Efficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective study.门诊静脉用抗生素治疗感染性心内膜炎的疗效和安全性:一项十年前瞻性研究。
Enferm Infecc Microbiol Clin. 2011 Oct;29(8):587-92. doi: 10.1016/j.eimc.2011.05.007. Epub 2011 Jun 30.
7
Establishment of an outpatient and home parenteral antimicrobial therapy service at a London teaching hospital: a case series.伦敦一家教学医院门诊及家庭肠外抗菌治疗服务的建立:病例系列研究
J Antimicrob Chemother. 2009 Sep;64(3):630-4. doi: 10.1093/jac/dkp212. Epub 2009 Jun 23.
8
A pilot study of oral fleroxacin given once daily in patients with bone and joint infections.一项针对骨与关节感染患者每日一次口服氟罗沙星的初步研究。
Am J Med. 1993 Mar 22;94(3A):177S-181S.
9
[Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].利奈唑胺治疗肌肉骨骼系统耐抗生素革兰氏阳性菌感染
Acta Chir Orthop Traumatol Cech. 2006 Oct;73(5):329-33.
10
Supervised self-administration of outpatient parenteral antibiotic therapy: a report from a large tertiary hospital in Australia.门诊胃肠外抗生素治疗的监督自我给药:来自澳大利亚一家大型三级医院的报告。
Int J Infect Dis. 2015 Jan;30:161-5. doi: 10.1016/j.ijid.2014.11.021.

引用本文的文献

1
Outpatient parenteral antimicrobial therapy (OPAT) in Germany: insights and clinical outcomes from the K-APAT cohort study.德国的门诊患者抗菌药物治疗(OPAT):K-APAT 队列研究的见解和临床结果。
Infection. 2024 Aug;52(4):1407-1414. doi: 10.1007/s15010-024-02199-9. Epub 2024 Mar 13.
2
Current Status of Outpatient Parenteral Antimicrobial Therapy in Korea: Experience of a Single University-Affiliated Acute-Care Hospital.韩国门诊胃肠外抗菌治疗的现状:一所大学附属医院急症医院的经验
Infect Chemother. 2023 Jun;55(2):185-193. doi: 10.3947/ic.2022.0092. Epub 2022 Dec 16.
3
Outpatient Parenteral Antimicrobial Therapy Practice in United Kingdom: A Single-center Experience.
英国门诊胃肠外抗菌治疗实践:单中心经验
Oman Med J. 2022 Nov 30;37(6):e442. doi: 10.5001/omj.2023.26. eCollection 2022 Nov.
4
Benefit of Echocardiography in Patients With Bacteremia at Low Risk of Endocarditis.超声心动图在感染性心内膜炎低风险菌血症患者中的益处。
Open Forum Infect Dis. 2018 Dec 11;5(12):ofy303. doi: 10.1093/ofid/ofy303. eCollection 2018 Dec.
5
Rates of and Risk Factors for Adverse Drug Events in Outpatient Parenteral Antimicrobial Therapy.门诊肠外抗菌治疗药物不良事件的发生率和危险因素。
Clin Infect Dis. 2018 Jan 6;66(1):11-19. doi: 10.1093/cid/cix733.
6
Clinical and cost-effectiveness, safety and acceptability of ommunity ntraenous ntibiotic ervice models: CIVAS systematic review.社区静脉抗生素服务模式的临床及成本效益、安全性与可接受性:CIVAS系统评价
BMJ Open. 2017 Apr 20;7(4):e013560. doi: 10.1136/bmjopen-2016-013560.
7
Setting up an outpatient parenteral antimicrobial therapy (OPAT) unit in Switzerland: review of the first 18 months of activity.在瑞士设立门诊肠外抗菌治疗(OPAT)单元:对运营头18个月的回顾
Eur J Clin Microbiol Infect Dis. 2016 May;35(5):839-45. doi: 10.1007/s10096-016-2606-z. Epub 2016 Feb 17.
8
Outpatient parenteral antimicrobial therapy with ceftriaxone for acute tonsillopharyngitis: efficacy, patient satisfaction, cost effectiveness, and safety.使用头孢曲松进行门诊胃肠外抗菌治疗急性扁桃体咽炎:疗效、患者满意度、成本效益及安全性
Infect Drug Resist. 2015 Aug 7;8:279-85. doi: 10.2147/IDR.S86341. eCollection 2015.
9
The Impact of an Infectious Diseases Transition Service on the Care of Outpatients on Parenteral Antimicrobial Therapy.传染病过渡服务对接受肠外抗菌治疗的门诊患者护理的影响。
J Pharm Technol. 2013 Oct;29(5):205-214. doi: 10.1177/8755122513500922.
10
Outpatient parenteral antimicrobial therapy for surgery patients: A comparison with previous standard of care.手术患者的门诊肠外抗菌治疗:与既往标准治疗的比较。
Can J Infect Dis Med Microbiol. 2013 Summer;24(2):74-8. doi: 10.1155/2013/754897.